Full Press Release Details
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies.
ZLAB
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Key Takeaway: argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies